SMARCA4 and neoplasm: Another important finding from the present study is that although BRG1 does not have a major role in GBM cell proliferation, BRG1 appears to play an important role in promoting the resistance of GBM cells to the DNA alkylating TMZ, which is a frontline chemotherapy used on GBM patients following tumour resection.